Pay in 4 interest-free payments of $6.50 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
This is a single rabbit study, not human evidence
If there is air in the syringe, push the liquid back into the vial and withdraw again
This is unusually broad and explains the growing interest
AOD-9604 is a synthetic analog of a pituitary hormone fragment
BMO Capital Markets analysts expect a slow launch, however, writing in a note to investors about challenges including a black box warning for risk of acute adrenal insufficiency or adrenal crisis with inadequate concomitant glucocorticoid therapy. The firm said it anticipates broad commercial access will not happen until the second half of 2025
